Explore the latest advances in the diagnosis, treatment, and management of Waldenström macroglobulinemia. This episode covers clinical features, the role of molecular markers in guiding care, indications for initiating therapy, management of IgM-related complications, emerging treatments, and future directions in patient care. Tune in for a practical and informative discussion. To access free Healthcare Professional accredited CME/CE continuing education activities, podcasts, and resources, please visit https://www.BloodCancerUnited.org/CE.